|
Kogan M.I., Sizonov V.V., Medvedev V.L., Palaguta G.A.
Horizontal pyeloureteral anastomosis in patients with UPJ obstruction has anatomical and functional advantages over vertical anastomosis
|
№4 / 2024
|
|
A.V. Zaitsev, I.S. Palagin
Fosfomycin: potential and perspectives
for use in urological practice
|
№6 / 2021
|
|
S.Yu. Shevchenko, E.V. Kulchavenya, D.P. Kholtobin
Method for evaluating the efficiency of treatment of urogenital tuberculosis
|
№4 / 2020
|
|
A.A. Kaputovskij
Tadalafil 5 mg once daily is a rationale option for simultaneous treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction
|
№6 / 2019
|
|
N.D. Akhvlediani, I.P. Matyukhov
Current role of sildenafil in the management of erectile dysfunction
|
№2 / 2018
|
|
A.G. Martov, S.V. Dutov, A.S. Andronov
Ultraminipercutaneous nephrolithotripsy in treating kidney stones
|
№2 / 2016
|
|
A.G. Martov, S.V. Dutov, A.S. Andronov, Z.I. Kil'chukov, R.A. Tahaev
New options of endoscopic treatment for kidney and ureter stones in obese patients
|
№4 / 2015
|
|
Neymark A.I., Nozdrachyov N.A.
Experience of the use of silodosin in acute urinary retention caused by benign prostatic hyperplasia
|
№4 / 2013
|
|
L.G. Spivak.
Efficacy and safety of use of likoprofit® in patients with chronic prostatitis and prostatic adenoma
|
№2 / 2013
|
|
F. Montorsi.
Pharmacological profile of silodosin
|
№2 / 2013
|
Русский
